CLAUDIA BALTA: Open Payments
NPI 1003153636 · RED OAK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 21 payments from 14 companies in 2025. Trend: 2023 $14 · 2024 $20 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Novo Nordisk Inc | 2 | $31 |
| Baxter Healthcare | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: MOUNJARO, PREVNAR 20, REXULTI, LEQVIO, CAMZYOS, Hillrom - Cardiac Ambulatory Monitor, LINZESS, Veozah.
Industry payments across IA — which companies pay providers there.
